Friday, November 16, 2012 Thursday, November 15, 2012 Wednesday, November 14, 2012 Tuesday, November 13, 2012 Monday, November 12, 2012- Cramer's 'Mad Money' Recap: Don't Let Politics Get You Downat TheStreet (Mon, Nov 12)
- Gilead Sciences And Celgene Liven Up Biotech ETFsat Investor's Business Daily (Mon, Nov 12)
- 3 Winning Trades Likely Missed Due to 'Fiscal Cliff'at CNBC (Mon, Nov 12)
- Movers roundup: Celgene, Clovis OncologyAP (Mon, Nov 12)
- 2 Reasons You Should Love This Biotech's Good Newsat Motley Fool (Mon, Nov 12)
- U.S. Stocks Erase Gains Amid Meeting on Greece Aidat Bloomberg (Mon, Nov 12)
- Celgene Corporation (CELG): Today's Featured Drugs Winnerat TheStreet (Mon, Nov 12)
- 4 Notables Rising on Unusual Volumeat TheStreet (Mon, Nov 12)
- Celgene rises on Abraxane pancreatic cancer dataAP (Mon, Nov 12)
- Celgene Reiterated at Buy and 3 Analyst-Reiterated Shares to Trackat Wall St. Cheat Sheet (Mon, Nov 12)
- Gilead and Other Big Movers on the Nasdaq on November 12, 2012at Investopedia (Mon, Nov 12)
- Gilead Among Healthcare's Biggest Movers on November 12, 2012at Investopedia (Mon, Nov 12)
- The Nasdaq Now: Gilead Sciences Hits 20-Year High; Groupon Finds No Redemptionat Minyanville (Mon, Nov 12)
Add CELG News to My Yahoo!  | |
|